Effects of MDM2 promoter polymorphisms on the development of cervical neoplasia in a Southeastern Brazilian population

Biomarkers. 2014 Dec;19(8):637-45. doi: 10.3109/1354750X.2014.962614. Epub 2014 Oct 1.

Abstract

We investigated the importance of two adjacent functional polymorphisms in the Murine Double Minute 2 (MDM2) gene, SNP285 G > C and SNP309 T > G, for the development of cervical lesions in a Southeastern Brazilian population (293 cases and 184 controls). MDM2 genotyping was performed by PCR-RFLP (Polymerase Chain Reaction-Restriction Fragment Length Polymorphism) and/or DNA sequencing. MDM2 SNP309 has potential as a biomarker of cervical neoplasia in non-smokers, patients with family history of cancer, or those who had late sexual debut (>16 years). Besides, this polymorphism may help identify women at risk of developing severe cervical lesion at a young age (<30 years).

Keywords: Age at onset; cervical neoplasia; genetic polymorphisms; susceptibility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Brazil / epidemiology
  • Ethnicity
  • Female
  • Humans
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic*
  • Proto-Oncogene Proteins c-mdm2 / genetics*
  • Risk Factors
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / genetics*
  • Young Adult

Substances

  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2